Page 64 - Biomarkers for risk stratification and guidance in heart failure

Management of chronic heart failure guided by individual NT-proBNP targets.
REFERENCES
1. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M. Nt-probnp testing for diagnosis and short-term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients: The international collaborative of nt-probnp study. European heart journal. 2006;27:330-337
2. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study I. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. The New England journal of medicine. 2002;347:161-167
3. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does b-type natriuretic peptide predict death and 3 cardiac events in patients with heart failure: Systematic review. Bmj. 2005;330:625
4. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA. Prognostic impact of plasma n-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: A substudy of the carvedilol prospective randomized cumulative survival (copernicus) trial. Circulation. 2004;110:1780-1786
5. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (n-bnp) concentrations. Lancet. 2000;355:1126-1130
6. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juilliere Y. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The stars-bnp multicenter study. Journal of the American College of Cardiology. 2007;49:1733-1739
7. Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM. N-terminal pro-b-type natriuretic peptide-guided treatment for chronic heart failure: Results from the battlescarred (nt-probnp-assisted treatment to lessen serial cardiac readmissions and death) trial. Journal of the American College of Cardiology. 2009;55:53-60
8. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP, Investigators T-C. Bnp-guided vs symptom-guided heart failure therapy: The trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (time-chf) randomized trial. JAMA : the journal of the American Medical Association. 2009;301:383-392
9. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K, Guideline ESCCfP. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The task force on acute heart failure of the european society of cardiology. European heart journal. 2005;26:384-416
10. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pierard L, Remme WJ, Task Force for the D, Treatment of Chronic Heart Failure of the European Society of C. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. European heart journal. 2005;26:1115-1140
11. Rector TS, Kubo SH, Cohn JN. Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo. The American journal of cardiology. 1993;71:1106-1107
12. Maisel A. Natriuretic peptide-guided therapy for heart failure: Ready for “battle” or too “scarred” by the challenges of trial design? Journal of the American College of Cardiology. 2009;55:61-64
13. McCullough PA, Sandberg KR. Sorting out the evidence on natriuretic peptides. Reviews in cardiovascular medicine. 2003;4 Suppl 4:S13-19
63